What do we know about COVID-19 media coverage and African stock markets? A time-varying connectedness analysis

被引:0
|
作者
Bossman, Ahmed [1 ]
Teplova, Tamara [2 ]
Umar, Zaghum [3 ,4 ]
机构
[1] Univ Cape Coast, Dept Finance, Sch Business, Cape Coast, Ghana
[2] Natl Res Univ, Higher Sch Econ, Fac Econ Sci, Dept Financial Market Infrastruct, Moscow, Russia
[3] Zayed Univ, Coll Business, Abu Dhabi, U Arab Emirates
[4] Lebanese Amer Univ, Adnan Kassar Sch Business, Beirut, Lebanon
关键词
African stock markets; coronavirus disease; COVID-19; media coverage; public mood; C32; G10; G11; N27; SOCIAL MEDIA; COMMODITIES; SENTIMENT; OIL;
D O I
10.1080/00036846.2024.2322571
中图分类号
F [经济];
学科分类号
02 ;
摘要
In this study, we explore the role of media coverage in the connectedness between African stock markets during the COVID-19 pandemic. Using the time-varying parameter autoregression connectedness metric and the Media Coverage Index (MCI), we analyse return and volatility connectedness between African stocks from January 2020 to October 2022. Our findings reveal that the MCI significantly drives risk transmission and financial market contagion from the global market to African markets. We document a peak in return (volatility) connectedness at 73% (55%) during the height of the pandemic in March 2020. The MCI transmits return shocks to all African stock markets except South Africa and Botswana, and volatility spillovers to all African markets. Our analysis suggests potential diversification attributes for stocks from Ghana, Mauritius, and Nigeria, which are strictly net receivers throughout the pandemic period. These findings have important implications for risk management, asset allocation, and market regulation decisions.
引用
下载
收藏
页数:15
相关论文
共 50 条
  • [31] What Do We Know and What Do We Need to Know about COVID-19's Implications on Business Economics? From Bibliometric Analysis to a Conceptual Framework
    Zhu, Zhuoyue
    Xie, Hongming
    SUSTAINABILITY, 2022, 14 (11)
  • [32] COVID-19 and cancer: do we really know what we think we know?
    Andrew G. Robinson
    Bishal Gyawali
    Gerald Evans
    Nature Reviews Clinical Oncology, 2020, 17 : 386 - 388
  • [33] COVID-19 and cancer: do we really know what we think we know?
    Robinson, Andrew G.
    Gyawali, Bishal
    Evans, Gerald
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (07) : 386 - 388
  • [34] Covid-19: What do we know about XBB.1.5 and should we be worried?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 380 : p153
  • [35] Cancer and COVID-19: what do we really know?
    Poortmans, Philip M.
    Guarneri, Valentina
    Cardoso, Maria-Joao
    LANCET, 2020, 395 (10241): : 1884 - 1885
  • [36] What we know about COVID-19 and its treatment
    Yakut, Zatiye Ayca Cevikelli
    Sakarcan, Sinem
    Sener, Goksel
    JOURNAL OF RESEARCH IN PHARMACY, 2020, 24 (05): : 602 - 616
  • [37] COVID-19 virus and children: What do we know?
    Morand, A.
    Fabre, A.
    Minodier, P.
    Boutin, A.
    Vanel, N.
    Bosdure, E.
    Fournier, P. E.
    ARCHIVES DE PEDIATRIE, 2020, 27 (03): : 117 - 118
  • [38] Asthma and COVID-19: What do we know now
    Hughes-Visentin, Alexzandra
    Paul, Anthea B. Mahesan
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2020, 14
  • [39] COVID-19 and lung cancer: What do we know?
    Serrano, G.
    Rogado, J.
    Pangua, C.
    Obispo, B.
    Martin Marino, A.
    Perez-Perez, M.
    Lopez-Alfonso, A.
    Lara, M. A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1026 - S1026
  • [40] COVID-19 in dental care: What do we know?
    Chmielewski, Marek
    Zalachowska, Oliwia
    Rybakowska, Weronika
    Komandera, Dominika
    Knura, Agata
    Albert, Adrian
    Kostanowicz, Julia
    Garbacz, Katarzyna
    JOURNAL OF ORAL MICROBIOLOGY, 2021, 13 (01)